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Background: Hantaviruses are causative agents of hemorrhagic fever with renal syndrome (HFRS) and
nephropathia epidemica (NE) in the Old World and hantavirus pulmonary syndrome (HPS) in the New World. There
is a need for time-saving diagnostic methods. In the present study, recombinant N antigens were used as antigens
in an immunochromatography strip (ICG) test to detect specific IgG antibodies.
Methods: The N-terminal 103 amino acids (aa) of Hantaan virus (HTNV), Puumala virus (PUUV) and Andes virus
(ANDV) nucleocapsid (N) protein were expressed in E. coli as representative antigens of three groups (HFRS, NE and
HPS-causing viruses) of hantavirus. Five different types of ICG test strips, one antigen line on one strip for each of
the three selected hantaviruses (HTNV, PUUV and ANDV), three antigen lines on one strip and a mixed antigen line
on one strip, were developed and sensitivities were compared.
Results: A total of 87 convalescent-phase patient sera, including sera from 35 HFRS patients, 36 NE patients and 16
HPS patients, and 25 sera from healthy seronegative people as negative controls were used to evaluate the ICG test.
Sensitivities of the three-line strip and mixed-line strip were similar to those of the single antigen strip (97.2 to
100%). On the other hand, all of the ICG test strips showed high specificities to healthy donors.
Conclusion: These results indicated that the ICG test with the three representative antigens is an effective
serodiagnostic tool for screening and typing of hantavirus infection in humans.
Keywords: Immunochromatography strip test, Hemorrhagic fever with renal syndrome (HFRS), Nephropathia
epidemica (NE), Hantavirus pulmonary syndrome (HPS)Background
Hantaviruses belong to the genus Hantavirus of the family
Bunyaviridae. Hantavirus virions contain three segmented
negative-sense RNAs designated S, M, L that encode a nu-
cleocapsid (N) protein, enveloped glycoproteins (Gn and
Gc), and an RNA-dependent RNA polymerase (L protein),
respectively [1]. Viruses in the genus Hantavirus contain
causative agents of two important rodent-borne febrile
zoonoses, hemorrhagic fever with renal syndrome (HFRS)
in the Old World and hantavirus pulmonary syndrome
(HPS) in the New World [2].* Correspondence: j_arika@med.hokudai.ac.jp
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unless otherwise stated.So far, 24 virus species that represent serotypes and ge-
notypes have been registered within the genus Hantavirus
by the International Committee on Taxonomy of Vi-
ruses [3]. Four of those virus species, Hantaan virus
(HTNV), Seoul virus (SEOV), Dobrava-Belgrade virus
(DOBV), and Puumala virus (PUUV), are known to cause
HFRS. The milder type of HFRS in Northern Europe,
caused by PUUV infection, was historically called
nephropathia epidemica (NE). Sin Nombre virus (SNV),
Andes virus (ANDV), Laguna Negra virus (LANV), and
many other related viruses are known as causative agents of
HPS [4]. There is a close association between the virus spe-
cies and their rodent hosts, probably due to the co-evolution
of rodent hosts and viruses for many thousands of years [5].
As a consequence, endemic areas of HFRS and HPSLtd. This is an Open Access article distributed under the terms of the Creative
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Figure 1 ICG test lines of the HTNV, PUUV and ANDV strips.
A: Test lines of the HTNV strip with sera from HFRS patients infected
with HTNV and SEOV. B: Test lines of the PUUV strips with sera from
an NE patient infected with PUUV and a seronegative sera from
healthy donor. C: Test lines of the ANDV strip with sera from HPS
patients infected with SNV, ANDV and LANV.
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of HFRS and HPS between different countries and con-
tinents have been reported [6-8]. Furthermore, more
than one hantavirus species is present in some regions,
and the severity of disease differs depending on the
virus [9]. In addition, clinical diagnoses of HFRS and
HPS patients are not effective in some cases as they repre-
sent mixed-syndrome between HFRS and HPS [10,11].
Therefore, screening and typing of hantavirus infections
provides important epidemiologic information.
Hantaviruses can be divided into antigenically distin-
guished species by neutralization tests, which show the
antigenic differences of Gn and/or Gc proteins. While, it
has been reported that hantavirus species can be divided
into three antigenic groups based on antigenic cross-
reactivity mainly at the N terminal end of N protein: group
I (HTNV, SEOV, and DOBV, which are derived from Muri-
nae rodents), group II (PUUV, and nonpathogenic vole-
borne hantaviruses, Tula virus, Prospect Hill virus, and
others, those are derived from Microtinae rodents) and
group III (SNV, ANDV and related New World
hantaviruses derived from Sigmodontinae and Neotominae
rodents) [12]. Therefore, three kinds of antigens from each
of the three antigenic groups I, II, and III are necessary for
screening of all of the rodent-borne hantavirus infections.
We previously developed an Escherichia coli (E.
coli) and baculovirus-expressed recombinant N pro-
tein for screening and serotyping patient samples in
an enzyme-linked immunoassay (ELISA) for HFRS
and HPS viruses [12,13]. Herein, we describe a pilot
study to assess a new rapid immunochromatography
(ICG) test with recombinant antigens using E. coli-
expressed common antigenic sites located in the N
terminal end of N protein for detection of specific
IgG antibodies in acute and convalescent samples of
patients with clinical infection caused by various
hantavirus species. In addition, the ICG test was eval-
uated for the ability to discriminate among the three
main hantavirus groups.
Results
ICG test lines of different ICG strips
The HTNV, PUUV and ANDV strips for IgG antibody
detection, which had one antigen line on one strip,
showed clear lines against homologous patient sera in-
fected with group I (HTNV and SEOV), group II
(PUUV) and group III (SNV, ANDV and LANV) vi-
ruses (Figure 1). On the other hand, no line was ob-
served with seronegative sera from healthy donors. In
some cases, the NE and HPS patient sera showed
cross-reactions to heterologous ANDV or PUUV
strips with lower intensity lines, but no cross-reaction
was observed in HFRS patient sera to ANDV or PUUVstrips (Figure 2A). Similarly, the HTNV strip showed
no test line with NE and HPS patient sera (data not
shown). As can be seen in Figure 2B, the mixed-line
strip showed a clear test line and control line to HFRS,
NE and HPS patient sera.Comparison of the results of ICG tests with patient sera
A total of 149 patient sera were examined for their IgG
antibodies to hantavirus by using 5 different ICG strips
(Table 1). Among them, 87 convalescent-phase pa-
tients sera were used for evaluation of the ICG test.
The HTNV, PUUV and ANDV strip showed sensitiv-
ities to homologous sera of 100%, 97.2% and 100%, re-
spectively. The three-line strip showed sensitivities to
homologous sera of 100%, 100% and 100%, respect-
ively. Mixed-line strip showed sensitivities to patient
sera of 100%, 97.2% and 100%, respectively.
The HTNV, PUUV and ANDV strips showed high sen-
sitivities to homologous sera with 100%, 92.3% and 100%
in acute-phase, respectively. The three-line strip showed
almost the same sensitivities: 100%, 88.5% and 100% in
Control Mixed 
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Figure 2 ICG test lines of the three-line strip and mixed-line
strip. A: Test lines of the three-line strip with sera from HFRS, NE
and HPS patients and a seronegative healthy donor. B: Test lines of
the mixed-line strip with sera from sera from HFRS, NE and HPS
patients and a seronegative healthy donor.
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showed sensitivities of 95%, 92.3% and 100% in acute-
phase sera, respectively.
The PUUV strip was able to detect antibodies in 14/
28 (50%) of the HPS patient sera (acute and convales-
cent) but in only 2/56 (3.6%) of the HFRS patient sera
(acute and convalescent). Similarly, the ANDV strip
was able to detect antibodies in 19/62 (30.6%) of the
NE patient sera (acute and convalescent) but in none
of the HFRS patient sera. The HTNV strip, on the
other hand, showed no cross-reactivity to NE and HPS
patient sera. The three-line strip showed the same
cross-reactive patterns as those of the HTNV, PUUV
and ANDV strips. In the three-line strip, all of the
cross-reactive sera showed a weak band to the heterol-
ogous antigen compared to that with the homologous
antigen, as shown in Figure 2.Comparison of sensitivities of the 5 different ICG strips
with ELISA
Representative sera from SEOV, ANDV or PUUV-infected
patients in convalescent phase were examined for anti-
body titers with the 5 different ICG strips and ELISA. The
single antigen strips, including the HTNV strip, ANDV
strip and PUUV strip, and the three-line strip showed the
same titers as that of ELISA with homologous combina-
tions. The mixed-line strip also showed the same titer as
that of ELISA (data not shown). Therefore, detection limit
of IgG antibody was almost the same as that of conven-
tional ELISA.
Discussion
In this study, N-terminal 103 aa of N protein of HTNV,
PUUV and ANDV expressed in E. coli were successfully
applied as antigens for an ICG test to detect hantavirus
IgG antibody in patient sera.
It has been reported that hantavirus N protein contains
immunodominant and cross-reactive epitopes, a character-
istic that is common to HFRS-causing viruses such as
HTNV, SEOV and DOBV (group I), NE-causing viruses
such as PUUV (group II) and HPS-causing viruses such as
SNV, ANDV, and LANV (group III), at about the N-
terminal 100 aa region.
In this study, we demonstrated that N-terminal 103 aa
of N protein of one virus from each group were useful
antigens in the ICG test for a rapid and simple serological
test to screen for hantavirus IgG antibodies in human sera.
Five different types of ICG test strips were evaluated. Sen-
sitivities were almost the same for all of the ICG strips
and ELISA test. The three-line strip was considered to be
the most effective as it covered all of the hantavirus in-
fections as well as distinguishing its antigenic groups.
Unrecognized cases of hantavirus infection might exist
even in countries where HFRS or HPS prevalence has
not been reported. To know the actual situation of
hantavirus prevalence, serological surveillance against
all of the serotypes of hantavirus is required. Particu-
larly in Europe and Far Eastern Asian regions, both
HFRS and NE-causing viruses are co-circulating [14,15].
For this purpose, the multiplex three-line strip ICG test is
considered to be the most useful for a rapid and safe sero-
logical test as it covers all antigenic groups of human
pathogenic hantaviruses. Furthermore, the ICG test was
applicable to diluted whole blood instead of serum spec-
imens [16]. This allows the use of the ICG test in field
surveillance or in resource-limited settings where ad-
equate laboratory equipment is not available. An ICG
test to detect IgM antibody has been reported for diag-
nosis of NE [17,18]. Our ICG tests were developed for
IgG antibody detection for the purpose of retrospective
seroepidemiological study. Although the rates of detection
of anti-hantavirus IgG antibody evaluated with convalescent







ELISA Single antigen-strip Three-line strip Mixed-line
strip (+)IgG (+) IgM (+) HTNV (+) PUUV (+) ANDV (+) HTNV (+) PUUV (+) ANDV (+)
HFRS HTNV or
SEOV
acute 21 19 17 21 (100%) 1 (4.7%) 1 (4.7%) 21 (100%) 1 (4.7%) 0 (0%) 20 (95%)
conv.a 35 35 20 35 (100%) 1 (2.8%) 0 (0%) 35 (100%) 1 (2.8%) 0 (0%) 35 (100%)
NE PUUV acute 26 21 24 0 (0%) 24 (92.3%) 2 (7.7%) 1 (3.8%) 23 (88.5%) 10 (38.5%) 24 (92.3%)
conv. 36 36 5 0 (0%) 35 (97.2%) 17 (47.2%) 0 (0%) 36 (100%) 7 (19.4%) 35 (97.2%)
HPS SNV, ANDV
or LANV
acute 12 7 4 0 (0%) 4 (33.3%) 12 (100%) 0 (0%) 3 (25%) 12 (100%) 12 (100%)
conv. 16 16 3 0 (0%) 10 (62.5%) 16 (100%) 0 (0%) 8 (50%) 16 (100%) 16 (100%)
Seronegative
healthy donar
- - 25 0 0 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
aConvalescent.
Twenty-one HFRS patient sera from China, 9 NE patient sera from Germany, 35 NE patient sera from Sweden, 11 HPS patient sera from U. S. A., and 17 HPS
patient sera from Argentina were used in this study.
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phase NE patient serum showed negative results in both
single PUUV strip and mixed-line strip. This specimen
showed low ELISA OD values and made the sensitivities
of ICG tests for NE low (97.2%) comparing to HPS and
HFRS (100%). Totally, three-line strip showed relatively
better sensitivity than those of single-antigen and mixed-
line strips by evaluation with convalescent.
On the other hand, antibody-positive rates in acute-phase
sera (88.5 - 100%) were slightly lower than those in
convalescent-phase sera. This might be due to the lower
IgG antibody titer in acute-phase sera. Furthermore, 3
of the ICG-negative sera from NE acute patients
(Table 1) were collected 4 and 5 days after onset of the
disease. These results indicated the limitation of these
ICG strips. All of the patient sera used in this study were
derived from patient with confirmed hantavirus infection.
Therefore, even if sera were negative in ELISA, they were
considered as true positive. Although several sera from
acute-phase patients were IgG-negative in ELISA, the re-
sults of sensitivities from acute-phase patients must be in-
formative for the use of these ICG strips.
Protein A binds with high affinity to human IgG anti-
body molecule as well as to human IgM antibody mol-
ecule with moderate affinity. Therefore, our ICG test
which utilized Protein A-labeled colloidal gold, able to de-
tect both hantavirus IgG antibody and lesser extent IgM
antibody. However, since the ICG test was judged by the
detection of visualized accumulated colloidal gold parti-
cles, it is difficult to distinguish IgG and IgM detection.
Therefore, the ICG test for specific to IgM antibody detec-
tion is necessary for detecting antibody from acute-phase
patient sera and for differential diagnoses between acute
infection and past infection in endemic countries.
The three-line strip developed in this study enables a
homologous reaction and a hererologous cross-reaction
to be easily distinguished by the intensity of lines. On
the other hand, the mixed-line strip enables detection ofhantavirus antibody in all of the three antigenic groups
with high sensitivity.
Conclusion
This applicability indicates that a multiplex ICG strip or
the mixed-line strip or single antigen-strips were useful
for serological survey of hantavirus infections among hu-
man. Depending on the situation, these strips were ef-
fective for survey. To test imported cases found in non-
endemic countries, one strip have to screen for various
antigens including similar infectious diseases, such as
leptospirosis, severe fever with thrombocytopenia syn-
drome (SFTS) and other viral hemorrhagic fever. On the
other hand, in endemic area and its neighbor, use of sin-
gle antigen strip might be enough for screening. These
ICG strips reported in this paper would be a useful tool
for serological surveillance of hantavirus infection.
Methods
cDNAs
cDNAs containing coding information for N of ANDV [8],
HTNV strain 76–118 [19], and PUUV strain CG1820 [20]
were used for the preparation of truncated N antigens.
Sera
A total of 56 serum specimens from 21 HFRS patients (12
pairs, 4 triads and 5 quartets, including acute-phase
serum) were kindly provided by H. Wang of the Institute
of Virology, Chinese Academy of Preventive Medicine,
Beijing, China. These sera were confirmed to be positive
for hantavirus infection by neutralization test as previously
reported [21]. Because of the lack of precise records,
the sera collected the first time were regarded as
acute-phase sera and rest of them were regarded as
convalescent-phase sera.
Nine NE patient sera, including 4 acute-phase sera
and 5 convalescent-phase sera, were kindly provided by
Dr. Rainer Ulrich, Friedrich-Loeffler Institut, Federal
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and Emerging Infectious Diseases, Germany. These sera
were confirmed to be antibody-positive to PUUV by a
neutralization test [22,23]. A total of 17 sera, including 4
acute-phase and 13 convalescent-phase sera, were kindly
provided by Dr. Ake Lundkvist, Swedish Institute for In-
fectious Disease Control, Sweden and were confirmed to
be antibody-positive to PUUV as previously described
[24]. In addition, a total of 18 paired (acute and
convalescence-phase) sera obtained from hospitalized
NE patients in northern Sweden were included. They
were confirmed to be infected with PUUV by an indirect
immunofluorescence assay (IFA).
Eleven serum specimens from HPS patients infected
with SNV in the United States were kindly supplied
by Brian Hjelle of the University of New Mexico
Health Sciences Center. Eleven serum specimens from
HPS patients infected with ANDV and six serum
specimens from HPS patients infected with LANV,
which is the most antigenically related to ANDV and
is co-circulating in the area where ANDV is prevalent,
were obtained from Dr. Delia Enria, Instituto Nacio-
nal de Enfermedades Vigrales Humanas and Dr. Julio
I. Maiztegui, Pergamino, Argentina. Twenty-five sera
from healthy donors that were confirmed to be hanta-
virus antibody-negative were used as a negative con-
trol group [24]. This study was approved by the ethics
committee of Hokkaido University Graduate School of
Medicine.
Preparation of recombinant antigens
Hantavirus N protein possesses an immunodominant anti-
genic region within the N-terminus of about 100 aa
[25-27]. In this study, N-terminal 103 aa of N protein of
HTNV (HS103), PUUV (PUU103) and ANDV (AND103)
were selected as representative antigens of the three anti-
genic groups. HS103 and PUU103 were expressed as an
NUS and 6 X histidine -tagged recombinant protein using
the pET43.1 plasmid vector (Novagen, Madison, WI, USA)
and E. coli host strain BL21 (Novagen pET System Manual
10th ed.) as described previously [16,23]. The coding region
of AND103 was amplified using primers ANDVSATG-speI
(5′-aaaactagtatgagcaacctccaagaa-3′) and ANDVS103stop-
xho1 (5′ - aatctcgagttaatccaggacatttccata -3′) by a previously
described procedure [12]. A TAA stop codon, indicated
by an underline, was added to terminate recombinant
protein translation. Additional target sequences for the
restriction enzymes SpeI and XhoI are indicated by
italics. Fragments were cloned into the SpeI/XhoI re-
striction site of the pET43.1 vector in-frame with the
NUS and histidine (his)-tag, and the resultant plasmids
were introduced into E. coli host BL21 (DE3). HTN103,
PUU103 and AND103 were purified using HisTrap HP
columns (Amersham, Piscataway, NJ, USA) according tothe manufacturer’s instructions. Purified antigens were
evaluated by SDS- PAGE analysis followed by protein
staining with Simply blue (Invitrogen, Carlsbad, CA, USA,
data not shown).Enzyme-linked immunosorbent assay (ELISA)
(i) IgG ELISA
Ninety-six-well plates were first coated with 1 μg/ml of
HS103, PUU103 or AND103 in PBS for 1 h at 37°C as a
capture antigen. After being washed three times with
PBS containing 0.05% Tween 20 (PBS-T), the wells were
blocked with PBS containing 3% bovine serum albumin
(BSA) for 1 h at 37°C. After blocking, human sera at 1:200
dilution with ELISA buffer (PBS containing 0.5% BSA and
0.05% Tween 20) were added to the wells. After incuba-
tion for 1 h at 37°C, the wells were washed three times
with PBS-T. Bound antibody was detected with horse-
radish peroxidase (HRP)-labeled goat anti-human IgG
antibody (Invitrogen™) for 1 h at 37°C. After being
washed as above, color reactions were performed with
o-phenylenediamine dihydrochloride (OPD) (Sigma-Aldrich,
St. Louis, MO) and allowed to develop for 10 min. Ab-
sorbance was measured at 450 nm by using a Spectra-
Max 340 microplate spectrophotometer (Molecular
Device, Sunnyvale, CA). The optical density (OD) of
each test sample was subtracted from the OD value of
the control antigen, which was a purified NUS-tag pro-
tein alone, run on the same plate. Samples with OD
values of less than 0.2 were considered negative for
IgG antibody.(ii) IgM ELISA
IgM ELISA was carried out as previously described [28].
Briefly, ninety-six-well plates were coated overnight at
4°C with goat anti-human-μ-chain antibody (Cappel,
Aurora, OH). After washing and blocking as described
above, patient sera at 1:200 dilution were added to cap-
ture IgM antibodies in sera. Then a recombinant N pro-
tein of HTNV, PUUV or ANDV, prepared by using a
baculovirus vector as described previously [12,13], was
added. To detect bound antigens, biotinylated MAb
clone E5/G6 against N protein of HTNV [29,30] was
added. After reaction with streptavidin-HRP conjugate
(Prozyme), the color was developed with TMB (3,3′,5,
5′-tetramethylbenzidine) for 15 min, and development
was stopped with 0.5 M sulfuric acid. Absorbance was
measured at 450 nm by using a SpectraMax 340 micro-
plate spectrophotometer (Molecular Device). Samples
with OD values of less than 0.2 were considered negative
for IgM antibody. Reagena Poc Puumala® was used for
detection of IgM antibody against PUUV in NE patient
sera at the Department of Clinical Virology, Umeå Uni-
versity Hospital [17,18].
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(i) Preparation of a conjugate pad
A glass-fiber conjugate pad (5 mm × 300 mm, GFCP103000,
MILLIPORE) was soaked in 0.5% casein in 20 mM PBS
(pH 7.0) for 20 min. The pad was washed with 3.0%
sucrose PBS and dried in air overnight. Protein A-
conjugated colloidal gold (Protein A-Colloidal Gold
conjugate, EY Laboratories, CA., USA) was put onto the
pad at 500 μl for both ICG strips “Single-antigen strip”
and “Mixed-line strip”, and at 1000 μl for the “three-line
strip” described as below. The pad was dried in air over-
night and kept at room temperature.
(ii) Preparation of a nitrocellulose membrane
HS103, PUU103 and AND103 antigens prepared as de-
scribed above and rabbit IgG (Vector Laboratories,
Burlingame, USA) were diluted with 0.05% casein sodium
in 2.5 mM PBS (pH 7.0) to adjust the concentrations toB

















Figure 3 Detection method and scheme of ICG strip. A: Structure of IC
placed at the test line and control line, respectively. The ICG strip consisted
brane and absorbent pad. Protein A-colloidal gold conjugate was kept in t
with 150 μl of PBS and then placed in a microtiter well. The strip was dipp
control line appeared.1 mg/ml and 0.15 mg/ml, respectively. Then they were
immobilized on a nitrocellulose membrane (Hi-Flow Plus
240 Membrane Card, 60 mm × 300 mm, Millipore) by
drawing a thin line with a pen (Copic Sketch Spare Nib,
Too Co. Ltd, Japan) at the test line position (antigen) and
control line position (rabbit IgG). ICG strips with HS103,
PUU103 and AND103 antigen lines are named HTNV
strip, PUUV strip and ANDV strip, respectively, in the
text. The ICG strip with three antigens on separated lines
in one strip is named a three-line strip, and the ICG strip
with a single antigen line of three mixed antigens is named
a Mixed-line strip in the text. After the membrane had
been dried at room temperature for 15 min, it was soaked
in 20 mM PBS with 0.5% casein (pH 7.0) for 20 min to
block the unsaturated area. Then the membrane was
washed with 3.0% sucrose in DDW and dried overnight at
room temperature. Finally, a sample pad (20 mm ×
300 mm, Chromatography Paper 3MM Chr, Whatman),  
gen Rabbit IgG  




4 mm overlap   









G strip. N-terminal 103 amino acids of N protein and rabbit IgG were
of 4 membrane pads: sample pad, conjugate pad, nitrocellulose mem-
he conjugate pad. B: Detection method. Two μl of serum was diluted
ed in the solution. After standing still for 15 min, the test line and/or
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pad (50 mm × 300 mm, Cellulose fiber sample pad
CFSP203000, Millipore) were assembled on a membrane
card (Millipore). Then the combined membranes were cut
into 3-mm-wide strips by using a paper cutter (Kokuyo,
PT62, Japan). The structure of the ICG strip is shown in
Figure 3A. The ICG strip was stored at room temperature
in a dry and dark box until use.
(iii) Procedure for the ICG test
Serum dilution was prepared by mixing 2 μl of serum
with 150 μl of PBS in a microplate well, and an ICG
strip was directly put into the well (Figure 3B). After
standing still for 15 min, the ICG line was examined by
the naked eye. A serum sample that showed both test
and control lines was regarded as positive, and a serum
sample that showed only the control line was regarded
as negative.
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